GENEVA: The World Health Organisation (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use, Xinhua reported.
"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective, and quality assured following two doses of the inactivated vaccine," WHO Director-General Tedros Adhanom Ghebreyesus said at a WHO press briefing on Tuesday.
"Furthermore, the easy storage requirements of CoronaVac make it very suitable for low resource settings," he added.
In an official press release, WHO Assistant Director-General for Access to Health Products Mariangela Simao said: "The world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe."
"We urge manufacturers to participate in the COVAX Facility, share their know-how and data and contribute to bringing the pandemic under control," she said.
COVAX is a global coalition that works to ensure fair and equitable access to COVID-19 vaccines around the world.
The CoronaVac vaccine, developed by Sinovac Life Sciences Co, Ltd based in Beijing, is also an inactivated vaccine, like the other and the first COVID-19 vaccine from China -- the Sinopharm vaccine, which was validated earlier last month for WHO emergency use.
Apart from the two Chinese vaccines, WHO has previously listed the COVID-19 vaccine developed by Pfizer/BioNTech, two versions of AstraZeneca/Oxford vaccine, the Janssen vaccine, and the Moderna vaccine for emergency use.
According to WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), the Sinovac vaccine is recommended for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks.
The vaccine efficacy results showed that the Sinovac vaccine prevented severe COVID-19 and hospitalisation in 100 per cent of the studied population.
However, as few people over 60 years old were enrolled in clinical trials, SAGE said the Sinovac vaccine's efficacy could not be estimated in this age group.
"There is no reason to believe that the vaccine has a different safety profile in older and younger populations," the WHO statement said, adding that SAGE is not recommending an upper age limit for the vaccine, because data collected in multiple countries and supportive immunogenicity data suggest the vaccine is likely to have a protective effect in older persons.
As in the cases of previously validated vaccines, WHO recommends that countries using the Sinovac vaccine in older age groups conduct safety and effectiveness monitoring to verify the expected impact and contribute to making the recommendation more robust for all countries.
Assessment by SAGE has shown that the Sinovac vaccine had been authorised by 32 countries or jurisdictions for use in adults 18 years or older, where 260 million doses have been distributed to the public in domestic and overseas markets. No safety concerns have been identified from pre-clinical or repro/tox studies, while most adverse events were mild to moderate, such as pain at the injection site, headache, fatigue and myalgia.
As more than 80 per cent of the COVID-19 vaccine doses globally have been administered in high-and upper-middle income countries and just 0.3 per cent in low-income countries, according to WHO's statistics, the two Chinese vaccines, with WHO's validation for emergency use, are expected to accelerate vaccine roll-out in many low-and middle-income countries through purchase and delivery by the WHO-led COVAX international COVID-19 vaccine initiative.
China has already decided to provide 10 million COVID-19 vaccine doses to the COVAX initiative to meet the urgent needs of developing countries, a concrete step to deliver on the promise to make vaccines a global public good.
-- BERNAMA
Bernama
Wed Jun 02 2021
The vaccine efficacy results showed that the Sinovac vaccine prevented severe COVID-19 and hospitalisation in 100 per cent of the studied population. REUTERSpic
Lebih 2,000 trak bantuan Gaza terkandas di sempadan Rafah
Lebih 2,000 trak yang membawa bantuan kemanusiaan dan barangan komersial terkandas di sempadan Rafah di Mesir.
Bebas atau dakwa? Nasib ibu bapa Zayn belum jelas
Nasib ibu bapa kanak-kanak autisme Zayn Rayyan Abdul Matiin, sama ada dituduh atau dibebaskan dengan jaminan polis masih menjadi tanda tanya.
Ini kerana tempoh lanjutan reman kali kedua bagi pasangan ini akan berakhir esok, bersamaan Khamis 13 Jun.
Difahamkan media akan berkampung di Mahkamah petaling jaya untuk mengikuti perkembangan kes ini.
Bersama Firdaus Azil untuk laporannya.
Ini kerana tempoh lanjutan reman kali kedua bagi pasangan ini akan berakhir esok, bersamaan Khamis 13 Jun.
Difahamkan media akan berkampung di Mahkamah petaling jaya untuk mengikuti perkembangan kes ini.
Bersama Firdaus Azil untuk laporannya.
Teroka tawaran hebat pelancongan dalam negeri di MAH Domestic Tourism Fair 2024
Berlangsung selama dua hari pada 6 dan 7 Julai 2024 bertempat di Pavilion Bukit Jalil, Kuala Lumpur.
Rokok, vape berpotensi penyebab mati pucuk
Rokok dan vape mempunyai bahan nikotin yang boleh menyebabkan salur darah menjadi keras atau 'Atherosclerosis.'
Apple ID dijenamakan semula menjadi Apple Account
Penjenamaan kepada Apple Account dilakukan bagi memberikan pengalaman log masuk yang konsisten merentas perkhidmatan dan peranti Apple.
Elon Musk tarik tuntutan saman ke atas OpenAI, Sam Altman
Tiada sebab diberikan mengapa saman ditarik dan pihak Elon Musk belum mengemukakan sebarang kenyataan rasmi mengenainya.
PM beri sumbangan pada penyampai Astro ARENA, isteri
Anwar yang diwakili Setiausaha Politik beliau Farhan Fauzi, menziarahi Akbar dan isterinya di hospital yang mengidap kanser usus tahap 4.
Pornografi boleh menyebabkan masalah mati pucuk - Pakar kesihatan lelaki
Para lelaki disaran agar tidak segan untuk mendapatkan rawatan di klinik atau mana-mana hospital.
Likes di X kini disorok untuk semua pengguna
Hanya pemilik akaun boleh melihat Likes peribadi selepas ini.
Malaysia garis tiga perkara utama demi kemerdekaan Palestin
Mohamad Hasan menegaskan, semua pihak harus menyokong usaha-usaha ke arah mencapai penyelesaian damai.
Negara anggota WHO lanjutkan perbincangan perjanjian pandemik setahun lagi
INB akan meneruskan mandatnya untuk menyampaikan perjanjian itu menjelang Perhimpunan Kesihatan Sedunia pada 2025, atau lebih awal.
Promosi berleluasa, tanpa kawalan antara faktor pengaruhi remaja jadi perokok kekal - KKM
Di bawah Akta 852, KKM akan memperketatkan larangan penjualan, pembelian dan penggunaan semua jenis produk merokok kepada orang belum dewasa (OBD) yang berumur kurang 18 tahun.
Menteri Palestin mahu AS desak Israel buka lintasan Rafah
Majed Abu Ramadan berkata tidak ada petunjuk bahawa pihak berkuasa Israel akan berbuat perkara berkenaan dalam masa terdekat.
Sistem kesihatan Gaza lumpuh, Israel dikecam teruk dalam mesyuarat tahunan WHO
Beberapa negara anggota turut menyalahkan Israel atas risiko kebuluran yang semakin meningkat di Gaza.
GPW14 instrumen penting bentuk masa depan ekosistem kesihatan sejagat
Malaysia optimis kerjasama dengan WHO melalui GPW14 akan membentuk masa depan kesihatan global.
WHO gesa Israel tarik balik sekatan bantuan ke Gaza
Saluran utama untuk bantuan perubatan ke enklaf dari Mesir telah terputus.
Tiada bekalan perubatan diterima di Gaza selama 10 hari - WHO
Penutupan lintasan Rafah ke Gaza oleh Israel telah menyebabkan "situasi yang sukar."
WHO luluskan vaksin denggi baharu TAK-003
TAK-003 merupakan vaksin lemah hidup yang mengandungi versi lemah dari keempat-empat serotip virus yang menyebabkan denggi.
Hari Jururawat Antarabangsa: 500 petugas perubatan terbunuh di Gaza sejak 7 Okt
Al-Daqran menyeru komuniti antarabangsa dan orang-orang yang bebas di dunia untuk melindungi petugas perubatan dan institusi kesihatan serta menjenayahkan serangan terhadap mereka.
Perbincangan perjanjian pandemik diteruskan selepas tarikh akhir: WHO
Kerajaan-kerajaan di seluruh dunia bersetuju lanjutkan perbincangan selama dua minggu lagi mengenai perjanjian penting berhubung pengendalian pandemik masa depan.